Cargando…
The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma
Glioblastoma (GBM) is a highly lethal cancer that is universally refractory to the standard multimodal therapies of surgical resection, radiation, and chemotherapy treatment. Temozolomide (TMZ) is currently the best chemotherapy agent for GBM, but the durability of response is epigenetically depende...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347012/ https://www.ncbi.nlm.nih.gov/pubmed/34361090 http://dx.doi.org/10.3390/ijms22158324 |